Sign in
Taking people in United StatesNo phase

Predicting diabetes after liver transplant in people with cirrhosis

Studies which tests predict diabetes after liver transplant in adults with cirrhosis.

Key facts

Who runs it
University of Chicago
Where
Chicago, United StatesSee the site
Trial code
Registry title
Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
Status
Recruiting
People taking part
60 people, planned
Started
12 Mar 2024
Expected to end
Jan 2031
Type of study
Observational
Record updated
7 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with cirrhosis (liver scarring) who come to a liver transplant clinic. It studies what predicts diabetes after a liver transplant.

Age
Over 18 years (record lists 18 Years to 75 Years).
Sex
All sexes can join.
Disease stage
Diagnosis of cirrhosis, being seen at a liver transplant clinic.

Main reasons for not taking part

  • Pregnant patients
  • People in prison
  • People who cannot give consent and have no representative to consent for them
  • People with implanted defibrillators or electrical devices that cannot be removed or turned off cannot have the body composition test
  • People with type 2 diabetes diagnosed more than 5 years ago cannot have the oral glucose tolerance test

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Patients presenting to liver transplant clinic with a diagnosis of cirrhosis
  • Age >18 yrs
  • Ability to understand and sign written consent form, or have a legally-authorized representative or proxy who can be approached for consent

Who cannot take part

  • Patients with a history of type 2 diabetes mellitus diagnosed > 5 years ago will be excluded from the Oral Glucose Tolerance Test portion of the study
  • Patients without consent
  • Patients with implantable cardioverter defibrillator devices or automated implantable cardioverter defibrillator devices will be excluded from the bio-electrical impedance analysis portion of the measurements
  • Patients with unremovable electrical medical devices or devices that cannot turn off will be excluded from the bio-electrical impedance analysis measurements
  • Pregnant patients
  • Incarcerated patients

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Where in United States

  • University of Chicago Medical CenterChicago, United StatesContact: Alan L Hutchison, MD, PhDTaking people

About the trial

What the trial wants to find out

The goal of this observational study is to establish risk factors for post-transplant in adult individuals with cirrhosis without diabetes undergoing liver transplant evaluation.

Read full original descriptionShow less

The question being addressed is: can laboratory work, anthropometric tests, functional tests, imaging, and advanced measurements such as wrist actigraphy, continuous glucose monitoring, or oral glucose tolerance testing predict the development of diabetes after liver transplant?

Participants will be asked to periodically participate in wearing a continuous glucose monitor and wrist actigraph and obtain an oral glucose tolerance test both before and after liver transplant.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
Plain-language title
Predicting diabetes after liver transplant in people with cirrhosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT06950788, who can take part
Record updated
7 May 2026